Ultragenyx Pharmaceutical
RARE
RARE
294 hedge funds and large institutions have $2.05B invested in Ultragenyx Pharmaceutical in 2026 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 124 increasing their positions, 83 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 286 → 294 (+8)
8% more call options, than puts
Call options by funds: $27.9M | Put options by funds: $25.8M
5% less capital invested
Capital invested by funds: $2.16B → $2.05B (-$108M)
Holders
294
Holding in Top 10
6
Calls
$27.9M
Puts
$25.8M
Top Buyers
| 1 | +$72.5M | |
| 2 | +$69M | |
| 3 | +$53.5M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$46.3M |
| 5 |
Two Sigma Investments
New York
|
+$40.1M |
Top Sellers
| 1 | -$84M | |
| 2 | -$63.8M | |
| 3 | -$53.6M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$46.4M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$33.4M |
